Your FDA Registration Is in the Distributor's Name and You Are Switching Distributors: How to Get It Back

Step one: list every product and who actually holds its registration

Before any negotiation, build a table: for each product, the registration or notification number, the holder's name, the category, the validity date, and who holds the License to Operate it sits under. Many brand owners only discover at this point that it is not a few products in the distributor's name but all of them — or that the same product was filed by different entities at different times and the numbers do not line up. Once the table exists, both your leverage and your time pressure become obvious.

Collect the underlying files at the same time: copies of the formulations, labels, test reports and foreign authorization letters that were submitted. Many brands handed everything to the distributor years ago and kept nothing. They discover this only when they need to file again and must rebuild the dossier from scratch. Ask your R&D, production and original project people for every document now and store it in the brand's own records.

Also check the old distributor's own License to Operate. If the holder's license lapses, registrations under it can be affected, and you are usually the last to hear. For LTO renewal and what happens after a lapse, see how FDA LTO renewal works. If the old distributor's license is close to expiry anyway, that changes both your negotiating position and your timetable.

Finally, note which products drive most of your revenue. You may not be able to move everything at once, and the table tells you which registrations to fight for first and which can safely wait for the second wave.

Run both tracks together: transfer and re-filing are not either-or

A transfer depends on the old holder's cooperation, which you do not control; a fresh filing is in your hands but takes time. Start both at once and use whichever comes through first. On the first track, you negotiate with the old distributor to issue documents consenting to the transfer or withdrawing the registration, and to cooperate on the filing. Whether that can be handled as an amendment or requires a new registration depends on the product category and current FDA requirements. Confirm it with the agency or a specialist agent rather than borrowing experience from a different category.

On the second track, you decide who the new holder will be: the new distributor, or the brand's own Philippine company. The new holder must have a License to Operate covering the category, plus a full dossier and freshly issued, authenticated foreign authorizations. For how registration and the LTO relate, see the FDA product registration guide.

Many brands use this moment to move registrations into their own company, so that no future distributor change can hold them hostage. That requires a local entity able to obtain an LTO. It takes longer but solves the problem permanently. Whether it is worth it depends on the size of your Philippine business and how long you plan to stay — a commercial judgment, not a race.

Whichever route you choose, put one person in charge of both tracks and review progress weekly. Two tracks run by two different people tend to drift, and the fallback route ends up starting too late to matter.

Getting the old distributor to cooperate: put it in the overall settlement

Whether the old distributor cooperates depends on what it gets out of the separation, so do not negotiate the registration on its own — make it part of the overall exit package. A separation usually settles several accounts: whether remaining stock is bought back, how receivables and payables are closed, how customers and channels are handed over, and how any trademark license ends. The registration is one of the heaviest cards the distributor holds. What you can offer in exchange is typically buy-back terms, a transition sales arrangement or settlement timing. The overall framework is in ending an exclusive distribution agreement.

Start by rereading the original distribution agreement. Look for clauses on registration ownership and on transfer or withdrawal obligations after termination. If such clauses exist, your position is much stronger. If not, you are relying on commercial leverage and whatever legal claims your lawyer thinks are available.

Whatever is agreed must be put in writing: which documents the distributor will provide, by when, who files them, and what happens to products sold under the old numbers during the transition. Cooperation that exists only as a verbal promise tends to evaporate the moment the relationship sours. If the distributor flatly refuses or counter-claims against you, pause the negotiation, hand it to your lawyer, and put full effort behind the re-filing track instead of waiting for a change of heart.

It also helps to sequence the talks. Agree the stock and money questions in principle first, because that is what the distributor cares about most, and tie the release of the final payment to delivery of the signed registration documents. Paying everything up front and hoping for cooperation afterwards removes the only reason the other side has to keep its word.

Getting through the gap: stock, labels and channels

Until the transfer or new filing is complete, the main risk is a mismatch between the registered holder and whoever is actually selling the goods. Handle stock and sales strictly by the rules during this period. Stock already labeled under the old distributor's registration generally needs to be sold or disposed of by the old holder, or with its agreement. The new distributor should not simply sell it as its own, because the importer and holder details on the label would not match the actual seller, which is hard to explain in an inspection.

Only start using new labels once the new registration or amendment is in place, and change every field showing the holder, importer and registration number. Do not print early and release early. For goods in transit, agree with your customs broker in advance which entity and which number will be used at clearance, so you do not find out at the port that the declaring party does not match the registration.

Talk to your channels early. Large retailers, pharmacy chains and e-commerce platforms usually require the registration details of a listed product to match the supplying entity. Telling them about the transition and the expected timing of the new registration is far better than explaining after a delisting. If a product has already been named or pulled, see what to do when FDA publicly names your product. Keep a written log of what each channel was told and when, so commitments made in the transition can be honored consistently later.

If the old distributor refuses and keeps importing under the old registration

If the old distributor will not cooperate and keeps bringing in your products from elsewhere under the registration in its name, you are no longer dealing only with a registration problem — it is also about your trademark and control of your channels. First, confirm whether the Philippine trademark is registered in the brand's own name. If it is, continued sales under your brand may amount to infringement, and that is your strongest tool. If the trademark is also in the distributor's name, things are much harder and ownership has to be resolved first; see getting your trademark back from a distributor.

Second, if the distributor sources from unauthorized channels and keeps selling under the old number, this overlaps with diversion and parallel imports; see dealing with gray-market and parallel imports.

Whether you can ask the regulator to act on the registration itself — for example by explaining that the authorization behind it has ended — depends on the category rules and the facts at the time. That is for your lawyer to judge. Do not write to FDA yourself accusing the distributor. Throughout this stage your main line stays the same: get the new registration in place quickly so compliant replacement stock reaches the market. The longer the old registration occupies the space, the more of your channel you lose, and the harder it becomes to win those retailers back.

Keep a dated file of everything you observe in the market during this period — listings, shelf photos, invoices from test purchases, and any correspondence with the old distributor. If the matter later becomes a formal dispute, a clean chronology of what was sold, by whom and under which registration number will save your lawyer a great deal of time.

Write it into the next agreement, and how YIXING can help

Put this lesson into your next distribution agreement: who holds the registrations, how they are transferred or withdrawn on termination, the distributor's duty and deadline to cooperate, and who owns copies of the files. Where possible, set up a local entity able to hold an LTO and keep registrations in the brand's name, with distributors only selling. If that is not feasible yet, at least require that every filing is shared with you and that post-termination cooperation is written into the contract.

Before signing a new distributor, verify that its LTO covers your category, how long it remains valid, and whether it has a history of penalties. If the new distributor's license runs into trouble, you will fall into the same hole again, only with a different partner holding the rope.

YIXING (SEC registration CS202009551; Bureau of Immigration accreditation CA-202624381-1) supports brands entering the Philippines with market access services and compliance retainer services: building a register of every registration and notification, setting up a brand-owned holder entity and coordinating its LTO, checking label and customs-declarant details through the transition, and bringing in licensed lawyers when a distribution dispute arises. We are a private consultancy with no affiliation to FDA or any other government agency, and we do not promise approval timelines or outcomes. Every case is different — consult a licensed lawyer; this article is not legal advice.

A practical checklist for the next contract negotiation: a registration ownership clause, a post-termination cooperation clause with a deadline, a right to receive copies of every submission and every regulator letter, and a clause dealing with labeled stock at the end of the relationship. Four clauses, written in at the start, avoid most of what this article describes.